Foundations Investment Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-7,131
| Closed | -$400K | – | 645 |
|
2023
Q2 | $400K | Sell |
7,131
-52
| -0.7% | -$2.92K | 0.01% | 406 |
|
2023
Q1 | $325K | Sell |
7,183
-6
| -0.1% | -$271 | 0.01% | 380 |
|
2022
Q4 | $292K | Sell |
7,189
-809
| -10% | -$32.9K | 0.01% | 347 |
|
2022
Q3 | $523K | Sell |
7,998
-740
| -8% | -$48.4K | 0.02% | 236 |
|
2022
Q2 | $635K | Buy |
8,738
+982
| +13% | +$71.4K | 0.03% | 194 |
|
2022
Q1 | $482K | Sell |
7,756
-17
| -0.2% | -$1.06K | 0.02% | 198 |
|
2021
Q4 | $543K | Buy |
7,773
+3,732
| +92% | +$261K | 0.02% | 192 |
|
2021
Q3 | $414K | Buy |
4,041
+1,788
| +79% | +$183K | 0.02% | 212 |
|
2021
Q2 | $325K | Buy |
+2,253
| New | +$325K | 0.02% | 221 |
|